Panel Discussion: What Does Good Look Like for Investors & Pharma? Defining Value & De-Risking Strategies to Attract Investment in Antifibrotics
Time: 2:00 pm
day: Conference Day One
Details:
As competition and innovation grow across fibrosis indications, clarity on what makes a compelling therapeutic story is more essential than ever. This panel brings together experts to explore how to shape preclinical packages that spark commercial interest and secure partnerships.
Key Discussion Points:
- What types of efficacy, durability, mechanism, safety, and translatability data do investors and pharma want to see at early stages to build confidence?
- Which companies, modalities, and strategies are resonating in the market today, and what differentiates them from the noise?
- How important is timing (first-in-class vs best-in-class), and what role do management teams, clinical strategies, and disease area focus play in the decision to invest or partner?
